FlowMetric Life Sciences and the Huck Institutes of the Life Sciences at Penn State University announce the creation of a long-term collaboration study assessing the impact on the Centre County community's potential exposure to COVID-19 by Penn State University students returning to campus.
Together with Penn State's Center for Clinical Research, the Huck Institutes will collect thousands of blood samples from Penn State students and members of the Centre County community at the beginning and end of each academic semester for four academic semesters.
The samples will be sent to FlowMetric, a GLP-compliant, CLIA-certified, High Complexity clinical laboratory located in Doylestown, PA for analysis. FlowMetric is providing validated serology testing under the FDA's Emergency Use Authorization mandate. The test detects the presence of anti-SARS-CoV-2 (COVID-19) IgG antibodies and will identify individuals who have mounted an immune response following viral exposure, even if they are asymptomatic.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox! Sign up now!
"COVID is a serious challenge that needs local and global focus. We are absolutely delighted to to be partnering with a dynamic and forward-looking Pennsylvanian biotech company on this study. We call it 'Data 4 Action' because we want to make a difference. It is clear that FlowMetric does too,” Andrew Read, the project leader with Huck Institutes, said. "This project is a natural extension to the FlowMetric vision of improving the lives of individuals through our cutting-edge science and expertise in immune monitoring" said Renold Capocasale, CEO & Founder of FlowMetric Life Sciences. "We are honored to be partnering with Penn State University, a world-renown center of research excellence.”
The results of the study will be reported to the PA Department of Health as part of ongoing surveillance in response to the COVID-19 pandemic.